Dakota Wealth Management Sells 1,759 Shares of Cencora, Inc. $COR

Dakota Wealth Management decreased its position in Cencora, Inc. (NYSE:COR) by 4.7% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 35,997 shares of the company’s stock after selling 1,759 shares during the period. Dakota Wealth Management’s holdings in Cencora were worth $11,250,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Cornerstone Wealth Group LLC raised its position in Cencora by 1.3% in the third quarter. Cornerstone Wealth Group LLC now owns 2,383 shares of the company’s stock worth $745,000 after acquiring an additional 30 shares during the period. Security Financial Services INC. boosted its holdings in shares of Cencora by 2.6% in the third quarter. Security Financial Services INC. now owns 1,325 shares of the company’s stock worth $414,000 after acquiring an additional 33 shares during the period. Hemington Wealth Management boosted its stake in Cencora by 12.0% in the 3rd quarter. Hemington Wealth Management now owns 327 shares of the company’s stock worth $102,000 after purchasing an additional 35 shares during the period. Quadcap Wealth Management LLC grew its stake in Cencora by 1.5% during the second quarter. Quadcap Wealth Management LLC now owns 2,409 shares of the company’s stock valued at $722,000 after acquiring an additional 36 shares in the last quarter. Finally, Howard Capital Management Inc. increased its holdings in Cencora by 2.5% during the 3rd quarter. Howard Capital Management Inc. now owns 1,499 shares of the company’s stock worth $468,000 after acquiring an additional 37 shares during the period. 97.52% of the stock is currently owned by institutional investors.

Insider Activity

In other Cencora news, EVP Silvana Battaglia sold 1,677 shares of the business’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $345.00, for a total value of $578,565.00. Following the completion of the sale, the executive vice president directly owned 18,796 shares of the company’s stock, valued at $6,484,620. The trade was a 8.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Robert P. Mauch sold 5,096 shares of the company’s stock in a transaction dated Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the sale, the chief executive officer owned 66,726 shares of the company’s stock, valued at approximately $23,669,713.98. The trade was a 7.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 15,220 shares of company stock valued at $5,282,867. Corporate insiders own 0.38% of the company’s stock.

Cencora Trading Up 1.4%

Shares of COR stock opened at $365.97 on Tuesday. The business has a 50-day moving average price of $349.72 and a two-hundred day moving average price of $332.01. Cencora, Inc. has a 12-month low of $241.48 and a 12-month high of $377.54. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. The firm has a market cap of $71.19 billion, a P/E ratio of 43.99, a price-to-earnings-growth ratio of 1.68 and a beta of 0.68.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 EPS for the quarter, beating the consensus estimate of $4.04 by $0.04. The firm had revenue of $85.93 billion for the quarter, compared to analyst estimates of $86.12 billion. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The company’s revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the company earned $3.73 EPS. Equities analysts anticipate that Cencora, Inc. will post 15.37 EPS for the current fiscal year.

Cencora Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Stockholders of record on Friday, February 13th will be issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Friday, February 13th. Cencora’s payout ratio is presently 28.85%.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Wells Fargo & Company raised their price target on shares of Cencora from $405.00 to $429.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. UBS Group increased their price objective on Cencora from $380.00 to $415.00 and gave the stock a “buy” rating in a research report on Friday, November 7th. Weiss Ratings upgraded Cencora from a “hold (c+)” rating to a “buy (b)” rating in a research report on Thursday, February 5th. JPMorgan Chase & Co. raised their price target on Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Finally, Wall Street Zen downgraded Cencora from a “buy” rating to a “hold” rating in a research report on Friday, November 28th. Eleven analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Cencora presently has a consensus rating of “Moderate Buy” and an average target price of $399.00.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.